Viewing Study NCT00310895

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2026-02-03 @ 7:00 AM
Study NCT ID: NCT00310895
Status: COMPLETED
Last Update Posted: 2015-12-24
First Post: 2006-04-04
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Dose Study of GRN163L Administered to Patients With Refractory or Relapsed Solid Tumor Malignancies
Sponsor: Geron Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Refractory View
None Relapsed View